Efficacy and safety of oral estriol for managing postmenopausal symptoms

Maturitas

Volumn 34, Issue 2, 2000, Pages 169-177

  Takahashi, Kentaro ^a   Manabe, Atsushi ^a   Okada, Masako ^a   Kurioka, Hiroko ^a   Kanasaki, Haruhiko ^a   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Climacteric symptoms; Estriol; Hormone replacement therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ESTRADIOL; ESTRIOL; FOLLITROPIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BREAST; CALCIUM BLOOD LEVEL; CLIMACTERIUM; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; EPIGASTRIC PAIN; FEMALE; HEART PALPITATION; HOT FLUSH; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MASTALGIA; POSTMENOPAUSE; SWEATING; ULTRASOUND; VAGINA BLEEDING;

ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; BONE AND BONES; BREAST; CLIMACTERIC; ENDOMETRIUM; ESTRADIOL; ESTRIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FLUSHING; FOLLICLE STIMULATING HORMONE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; LUTEINIZING HORMONE; MIDDLE AGED; POSTMENOPAUSE; SAFETY; SLEEP INITIATION AND MAINTENANCE DISORDERS; SWEATING; ULTRASONOGRAPHY, MAMMARY; UTERINE HEMORRHAGE;

EID: 0033973119     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00108-5     Document Type: Article

References (33)

1. Smith D.G., Prentice R., Thompson D.J., Herrmann W.L. Association of exogenous estrogen and endometrial carcinoma. N. Engl. J. Med. 293:1975;1164-1167.
2. Ziel H.K., Finkle W.D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N. Engl. J. Med. 293:1975;1167-1170.
3. Steinberg K.K., Thacker S.B., Smith S.J. et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. J. Am. Med. Assoc. 265:1991;1985-1990.
4. Colditz G.A., Hankinson S.E., Hunter D.J. et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 332:1995;1589-1593.
5. Marslew U., Overgaard K., Riis B.J., Christiansen C. The new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effect on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Obstet. Gynecol. 79:1992;202-210.
6. Ohta H, Ikeda T, Masuzawa T, Makita K, Suda Y, Nozawa S. Differences in axial bone mineral density, serum levels of sex steroids, and bone metabolism between postmenopausal and age- and body size-matched premenopausal subjects. Bone (NY) 1993;14:1119-26.
7. Head K.A. Estriol: safety and efficacy. Altern. Med. Rev. 3:1998;101-113.
8. Tzingounis V.A., Aksu F., Greenblatt R.B. Estriol in the management of the menopause. J. Am. Med. Assoc. 239:1978;1638-1641.
9. Yang T.S., Tsan S.H., Chang S.P., Ng H.T. Efficacy and safety of estriol replacement therapy for climacteric women. Chin. Med. J. (Taipei). 55:1995;386-391.
10. Koyama T., Aso T. Kampo medicine for menopausal women: evaluation with simplified menopausal index. Recent Prog. Kampo Med Obstet. Gynecol. 9:1992;30-34.
11. Kupperman H.S., Wetchler B.B., Blatt M.H.G. Contemporary therapy of the menopausal syndrome. J. Am. Med. Assoc. 171:1959;1627-1637.
12. Nauck M., Marz W., Haas B., Wieland H. Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated. Clin. Chem. 42:1996;424-429.
13. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-550.
14. Englund D.E., Elamsson K.B., Johansson E.D.B. Bio-availability of oestriol. Acta Endocrinol. 99:1982;136-140.
15. Kuhl H. Pharmacokinetics of oestrogens and progesterones. Maturitas. 12:1990;171-197.
16. Schneider H.P.G. Oestriol and the menopause: clinical results from a prospective study. Fioretti P., Martini L., Melis G.B., Yen S.S.C. Serono Symposium, The Menopause: Clinical, Endocrinological and Pathophysiological Aspects. 39:1982;523-533 Academic Press, London.
17. Montoneri C., Zarbo G., Garofalo A., Giardinella S. Effects of estriol administration on human postmenopausal endometrium. Clin. Exp. Obstet. Gynecol. 14:1987;178-181.
18. Wren B.G. Oestriol in the control of postmenopausal symptoms. Med. J. Aust. 1:1982;176-177.
19. Punnonen R., Soderstrom K.O. The effect of oral estriol succinate therapy on the endometrial morphology in postmenopausal women: the significance of fractionation of the dose. Eur. J. Obstet. Gynecol. Reprod. Biol. 14:1983;217-224.
20. Scairer C., Adami H.-O., Hoover R., Persson I. Cause specific mortality in women receiving hormone replacement therapy. Epidemiology. 8:1997;59-65.
21. Lippman M., Monaco M.E., Bolan G. Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 37:1977;1901-1907.
22. Lemon H.M. Pathophysiologic consideration in the treatment of menopausal patients with oestrogens; the role of oestriol in the prevention of mammary carcinoma. Acta Endocrinol. (Copenh.). 223:1980;S17-S27.
23. Keller P.J., Riedmann R., Fischer M., Gerber C. Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oesteriol in post-menopausal women. Maturitas. 3:1981;47-53.
24. Vahapassi J., Adlercreutz H. Effect of continuous oral administration of estriol on corpus luteum function. Contraception. 11:1975;427-439.
25. Englund D.E., Johansson E.D.B. A pharmacokinetic study on oestriol. Endometrial effect of oestriol treatment in postmenopausal women. Acta Endocrinol. 91(Suppl. 225):1979;2109.
26. Lindsay R., Cosman F. Estrogen in prevention and treatment of osteoporosis. Ann. NY Acad. Sci. 592:1990;326-333.
27. Nishibe A., Morimoto S., Hirota K. et al. Effect of estriol and bone mineral density of lumbar vertebrae in elderly and postmenopausal women. Jpn. J. Geriatr. 33:1996;353-359.
28. Minaguchi H., Uemura T., Shirasu K. et al. Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study. J. Obstet. Gynaecol. Res. 22:1996;259-265.
29. Nozaki M., Hashimoto K., Inoue Y., Sano M., Nakano H. Usefulness of estriol for the treatment of bone loss in postmenopausal women. Acta. Obstet. Gynaecol. Jpn. 48:1996;83-88.
30. Knopp R.H. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease. Obstet. Gynecol. 72(Suppl. 5):1988;23S-30S.
31. Dubey R.K., Gillespie D.G., Jackson E.K., Keller P.J. 17β-Estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertention. 31:1998;522-528.
32. Modena M.G., Rossi R., Muia N. Jr, Origliani G., Rombola O., Molinari R. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension. G. Ital. Cardiol. 28:1998;636-644.
33. Saletu B., Brandstatter N., Metka M. et al. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacology. 122:1995;321-329.